Jones George Patrick 4
4 · Biofrontera Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Biofrontera (BFRI) CCO George Patrick Jones Receives Award
What Happened
George Patrick Jones, Chief Commercial Officer of Biofrontera, was granted two compensation awards on March 4, 2026: a 50,000-share option grant and 50,000 restricted stock units (RSUs). Both awards are reported as derivative acquisitions at $0.00 per share (awarded for no cash consideration). The option vests in two equal installments (Sept 4, 2026 and March 4, 2027). The RSUs vest in two equal yearly installments beginning March 4, 2027 and, at the company's discretion, will be settled in shares, cash, or a mix within 60 days after vesting.
Key Details
- Transaction date: March 4, 2026; filing date: March 6, 2026 (filed promptly).
- Awards: 50,000 options (derivative) + 50,000 RSUs (derivative); grant price reported as $0.00 (awarded).
- Shares owned after transaction: not specified in the excerpt of the filing.
- Vesting: Options vest in two equal installments (Sept 4, 2026; Mar 4, 2027). RSUs vest in two equal annual installments starting Mar 4, 2027; settlement (shares/cash) within 60 days of vesting.
- Footnotes: F1 describes option vesting; F2/F3 describe RSU terms and discretionary cash/share settlement; F4 notes other options with different terms are not included.
- Transaction code: A (award/grant). This is a compensation grant, not a market purchase or sale.
Context
These awards are typical executive compensation grants intended to retain management and align incentives. They do not represent an immediate stock purchase or sale and only translate into economic value over time according to vesting and settlement terms. Options generally have value only if the stock price exceeds the exercise price (exercise price not shown in this excerpt); RSUs convert to shares or cash per the company’s settlement choice.
Insider Transaction Report
- Award
Restricted Stock Units
[F2][F3]2026-03-04+50,000→ 50,000 total→ Common Stock (50,000 underlying) - Award
Employee stock option (right to buy)
[F1][F4]2026-03-04+50,000→ 50,000 totalExercise: $0.90Exp: 2036-03-04→ Common Stock (50,000 underlying)
Footnotes (4)
- [F1]The option vests in two equal installments, the first of which will take place on September 4, 2026 and the second of which will take place on March 4, 2027.
- [F2]Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 3. The reporting person received the restricted stock units as an award for no consideration.
- [F3]The restricted stock units vest in two equal yearly installments for the first two years following the grant date, beginning on March 4, 2027. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
- [F4]Options with different terms are not included